ArticleCurrent oncology (Toronto, Ont.)2020

Emergency Department Utilization for Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis of Identification and Outcomes for Those Presenting for Immune-Related Adverse Events.

Ryan Holstead et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.